4.0 Article

Dilemmas in the management of venous thromboembolism in older patients

期刊

BRITISH JOURNAL OF HOSPITAL MEDICINE
卷 78, 期 10, 页码 552-557

出版社

MA HEALTHCARE LTD
DOI: 10.12968/hmed.2017.78.10.552

关键词

-

资金

  1. Bayer
  2. BMS-Pfizer
  3. Boehringer Ingelheim

向作者/读者索取更多资源

Venous thromboembolism most commonly affects older patients. Despite the high incidence in this population, challenges remain in terms of the understanding of its presentation, diagnosis and management. Old age is associated with multi-morbidities which may complicate the diagnosis of venous thromboembolism as signs or symptoms may be attributed to underlying medical conditions. The presence of certain comorbidities (such as congestive cardiac failure and chronic obstructive pulmonary disease) also increases the risk of venous thromboembolism, but could mimic the clinical features of pulmonary embolism. In addition, the physiological processes associated with ageing and factors such as immobility and malignancy, which are more common in older people, will further increase the thrombotic risk. Dilemmas also exist with treatment decisions because of the concomitant increased risk of bleeding, comorbidities, polypharmacy, frailty and the risk of falls.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据